| 000 | 01533 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513195301.0 | ||
| 264 | 0 | _c20000104 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0090-9556 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aErickson, D A | |
| 245 | 0 | 0 |
_aCharacterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. _h[electronic resource] |
| 260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cDec 1999 |
||
| 300 |
_a1488-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 |
_aBiotransformation _xdrug effects |
| 650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 |
_aDNA, Complementary _xgenetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aKetoconazole _xpharmacology |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
| 650 | 0 | 4 |
_aNevirapine _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aTroleandomycin _xpharmacology |
| 700 | 1 | _aMather, G | |
| 700 | 1 | _aTrager, W F | |
| 700 | 1 | _aLevy, R H | |
| 700 | 1 | _aKeirns, J J | |
| 773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 27 _gno. 12 _gp. 1488-95 |
|
| 999 |
_c10526305 _d10526305 |
||